Eticyclidine

Eticyclidine (PCE, CI-400) is a dissociative anesthetic drug with hallucinogenic effects. It is similar in effects to phencyclidine but is slightly more potent. PCE was developed by Parke-Davis in the 1970s and evaluated for anesthetic potential under the code name CI-400,[1] but research into PCE was not continued after the development of ketamine, a similar drug with more favourable properties.[2] PCE is slightly more potent than PCP and has similar effects, but its unpleasant taste and tendency to cause nausea made it less accepted by users. Due to its similarity in effects to PCP, PCE was placed into the Schedule 1 list of illegal drugs in the 1970s, although it was only briefly abused in the 1970s and 1980s and is now little known.

Eticyclidine
Clinical data
ATC code
  • none
Legal status
Legal status
  • AU: S9 (Prohibited)
  • CA: Schedule I
  • DE: Anlage I (Authorized scientific use only)
  • UK: Class B
  • US: Schedule I
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H21N
Molar mass203.329 g·mol−1
3D model (JSmol)
  (verify)

See also

References
  1. Levy, Leonard; Cameron, D. Ewen; Aitken, R. Cairns B. (1960). "Observation on Two Psychotomimetic Drugs of Piperidine Derivation–Ci 395 (Sernyl) and Ci 400". American Journal of Psychiatry. 116 (9): 843–844. doi:10.1176/ajp.116.9.843.
  2. Kalir, Asher; Edery, Habib; Pelah, Zvi; Balderman, D.; Porath, Gila (1969). "1-Phenylcycloalkylamine derivatives. II. Synthesis and pharmacological activity". Journal of Medicinal Chemistry. 12 (3): 473–477. doi:10.1021/jm00303a030.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.